Intestinal absorption of aluminium in renal failureDRÜEKE, Tilman B.Nephrology, dialysis, transplantation (Print). 2002, Vol 17, pp 13-16, issn 0931-0509, SUP2Conference Paper

Sel et santé : au carrefour de la science et de la politique = Salt and health : between sciences and politicDRÜEKE, Tilman B.Médecine et nutrition. 2004, Vol 40, Num 1, pp 18-24, issn 0398-7604, 7 p.Article

Correction de l'anémie des insuffisants rénaux chroniques : quelles cibles ?DRÜEKE, Tilman B.Néphrologie & thérapeutique. 2008, Vol 4, pp 1-8, issn 1769-7255, 8 p., HS2Article

Genetic aspects of secondary hyperparathyroidism in uremiaDRÜEKE, Tilman B.American journal of kidney diseases. 2001, Vol 38, Num 4, pp S143-S146, issn 0272-6386, SUP1Conference Paper

Risks Related to Metal Absorption: Proceedings of a Roundtable Meeting, San Francisco, CA, USA, 17 October 2001DRüEKE, Tilman B.Nephrology, dialysis, transplantation (Print). 2002, Vol 17, issn 0931-0509, 41 p., SUP2Conference Proceedings

Masterclass in nephrology: direct disease targeting in renal illness: from calcimimetics to cytokines, 16-17 May 2003, Barcelona, SpainDRüEKE, Tilman B.Nephrology, dialysis, transplantation (Print). 2004, Vol 19, issn 0931-0509, 80 p., SUP5Serial Issue

Treatment of secondary hyperparathyroidism with vitamin D derivatives and calcimimetics before and after start of dialysisDRÜEKE, Tilman B.Nephrology, dialysis, transplantation (Print). 2002, Vol 17, pp 20-22, issn 0931-0509, SUP11Conference Paper

Consommation de sel, PA, morbidité et mortalité = Diatary sodium intake, arterial pressure, morbidity and mortalityCHANARD, Jacques; DRÜEKE, Tilman B.Concours médical (Paris). 2001, Vol 123, Num 34, pp 2283-2286, issn 0010-5309Article

Calcium balance in haemodialysis―do not lower the dialysate calcium concentration too much (con part)DRÜEKE, Tilman B; TOUAM, Malik.Nephrology, dialysis, transplantation (Print). 2009, Vol 24, Num 10, pp 2990-2993, issn 0931-0509, 4 p.Article

Klotho spins the thread of life-what does Klotho do to the receptors of fibroblast growth factor-23 (FGF23)?DRÜEKE, Tilman B; PRIE, Dominique.Nephrology, dialysis, transplantation (Print). 2007, Vol 22, Num 6, pp 1524-1526, issn 0931-0509, 3 p.Article

Anaemia after renal transplantationVANRENTERGHEM, Yves.Nephrology, dialysis, transplantation (Print). 2004, Vol 19, pp v54-v58, issn 0931-0509, SUP5Article

Cadmium overload and toxicityJÄRUP, Lars.Nephrology, dialysis, transplantation (Print). 2002, Vol 17, pp 35-39, issn 0931-0509, SUP2Conference Paper

The need for better control of secondary hyperparathyroidismLOCATELLI, Francesco.Nephrology, dialysis, transplantation (Print). 2004, Vol 19, pp v15-v19, issn 0931-0509, SUP5Article

The potential role of aluminium in Alzheimer's diseaseCAMPBELL, Arezoo.Nephrology, dialysis, transplantation (Print). 2002, Vol 17, pp 17-20, issn 0931-0509, SUP2Conference Paper

Achieving therapeutic targets in the treatment of secondary hyperparathyroidismCUNNINGHAM, John.Nephrology, dialysis, transplantation (Print). 2004, Vol 19, pp v9-v14, issn 0931-0509, SUP5Article

Causes and therapy of microinflammation in renal failureSCHINDLER, Ralf.Nephrology, dialysis, transplantation (Print). 2004, Vol 19, pp v34-v40, issn 0931-0509, SUP5Article

Calcimimetics versus vitamin D: What are their relative roles?DRÜEKE, Tilman B.Blood purification. 2004, Vol 22, Num 1, pp 38-43, issn 0253-5068, 6 p.Conference Paper

Stopping a medical research project for financial reasonsDRÜEKE, Tilman B; DESCAMPS-LATSCHA, Béatrice; LOCATELLI, Francesco et al.Nephrology, dialysis, transplantation (Print). 2003, Vol 18, Num 10, pp 1982-1983, issn 0931-0509, 2 p.Article

Progression of vascular calcification in uraemic patients: can it be stopped?DRÜEKE, Tilman B; ROSTAND, Stephen G.Nephrology, dialysis, transplantation (Print). 2002, Vol 17, Num 8, pp 1365-1368, issn 0931-0509Article

Role of vitamin D in vascular calcification: bad guy or good guy?DRÜEKE, Tilman B; MASSY, Ziad A.Nephrology, dialysis, transplantation (Print). 2012, Vol 27, Num 5, pp 1704-1707, issn 0931-0509, 4 p.Article

Hyporesponsiveness to erythropoietic therapy in uraemic patients with secondary hyperparathyroidism: what is the evidence base?DRÜEKE, Tilman B.Nephrology, dialysis, transplantation (Print). 2003, Vol 18, issn 0931-0509, p. viii23, SUP8Conference Paper

Summary of the KDIGO guideline on anemia and comment: reading between the (guide)line(s)DRÜEKE, Tilman B; PARFREY, Patrick S.Kidney international. 2012, Vol 82, Num 9, pp 952-960, issn 0085-2538, 9 p.Article

Controversies in bone and mineral metabolism in chronic kidney disease: A bridge to improving healthcare outcomes and quality of lifeMOE, Sharon M; DRÜEKE, Tilman B.American journal of kidney diseases. 2004, Vol 43, Num 3, pp 552-557, issn 0272-6386, 6 p.Article

Disturbances of bone and mineral metabolism in chronic kidney disease: an international initiative to improve diagnosis and treatment. CommentaryDRÜEKE, Tilman B; MOE, Sharon M.Nephrology, dialysis, transplantation (Print). 2004, Vol 19, Num 3, pp 534-536, issn 0931-0509, 3 p.Article

Management of secondary hyperparathyroidism: The importance and the challenge of controlling parathyroid hormone levels without elevating calcium, phosphorus, and calcium-phosphorus productMOE, Sharon M; DRÜEKE, Tilman B.American journal of nephrology. 2003, Vol 23, Num 6, pp 369-379, issn 0250-8095, 11 p.Article